RID partners with DynaLIFE

DynaLIFE Medical Labs and RID Inc. are launching the first evaluation of the Hopper™ platform for urinary tract infection diagnostics. Tests commence summer 2021. Click to read more

Previous
Previous

UCalgary-led team develops rapid diagnostic tool for fighting bloodstream infections

Next
Next

RID secures UCalgary UCEED support